Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, during which she focused her research on molecular biology, epigenetics and infectious diseases.
Pliant Therapeutics is starting a multi-year research collaboration with Cleveland Clinic to speed the discovery of new druggable targets for gastrointestinal fibrosis, a common gut complication in patients with ... Read more
Crohn’s and Colitis Canada has awarded $2.7 million in grants to support nine Canadian researchers studying inflammatory bowel disease (IBD). The grants include seven Grants-in-Aid of Research, intended to advance ... Read more
People with inflammatory bowel disease (IBD) appear to have an increased risk of herpes zoster infection (shingles), and Canadian researchers warn that low vaccination rates have been insufficient to ... Read more
A preclinical study found that Cyxone’s investigational T20K therapy was able to reduce the immune system’s activity in an animal model of inflammatory bowel disease (IBD), showing promise as a treatment for ... Read more
Researchers have found that dietary therapy in children with chronic illnesses, such as inflammatory bowel disease (IBD), may increase their risk for unusual eating habits or eating disorders. The ... Read more
Pin It on Pinterest